Función vesical, tracto urinario superior y urodinamia en niños con disrafismo espinal
Contenido principal del artículo
Resumen
En México anualmente se registran cerca de 1,500 nacimientos con disrafismo espinal. 95% de ellos mostrarán vejiga neurogénica, primera causa de atención en el Servicio de Urología del CRIT Estado de México.
Detalles del artículo
Sección
Cómo citar
Referencias
Favazza TF, Koo HP. Myelodysplasia and Neurogenic Bladder. Updated: Mar 27, 2008. Disponible en: http://emedicine.medscape.com/ article/1015695-overview
Bauer SB. Neurogenic bladder: etiology and assessment. Pediatr Nephrol 2008; 23: 541-51.
DeLair SM, Eandi J, White MJ, Nguyen T, Stone AR, Kurzrock EA. Renal Cortical Deterioration in Children With Spinal Dysraphism: Analysis of Risk Factors. J Spinal Cord Med 2007; 30: S30-S34.
Alexander MA, Steg NL. Myelomeningocele: comprehensive treatment. Arch Phys Med Rehabil 1989; 70(8): 637-41.
Medina SA, Coutiño LB, Alvarado JG, Ramírez RJ. Epidemiología del mielomeningocele en niños menores de un año de edad en el Instituto Nacional de Pediatría. Rev Mex Med Fis Rehab 2001; 13(2): 50-4.
Rintoul NE, Sutton LN, Hubbard AM, Cohen B, Melchionni J, Pasquariello PS, Scott Adzick NS. New Look at Myelomeningoceles: Functional Level, Vertebral Level, Shunting, and the Implications for Fetal Intervention. Pediatrics 2002; 109: 409-13.
de Groat WC. A neurologic basis for the overactive bladder. Urology 1997; 50(Suppl. 6A): 36-52.
Karsenty G, Reitz A, Wefer B, Boy S, Schurch B. Understanding detrusor sphincter dyssynergia-significance of chronology. Urology 2005;
(4): 763-8.
Kuo HC. Satisfaction with urethral injection of botulinum toxin A for detrusor sphincter dyssynergia in patients with spinal cord lesion. Neurourol Urodyn 2008; 27(8): 793-96.
Castro-Diaz D, Taracena Lafuente JM. Detrusor-sphincter dyssynergia. Int J Clin Pract Suppl 2006; (151): 17-21.
Arlandis S, Ruiz JL, Martínez E. Las pruebas funcionales urodinámicas en el diagnóstico de la vejiga neurógena. Rehabilitación (Mad) 2005;
(6): 343-58.
Bauer SB, Hallet M, Khoshbin S, et al. Predictive value of urodynamic evaluation in newborns with myelodysplasia. JAMA 1984; 252: 650-2.
Flood HD, Ritchey ML, Bloom DA, Huang C, McGuire EJ. Outcome of reflux in children with myelodysplasia managed by bladder pressure monitoring. J Urol 1994; 152: 1574-7.
Edelstein RA, Bauer SB, Kelly MD, et al. The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy. J Urol 1995; 154: 1500-4.
Walsh PC, Retik A, Vaughan E, et al. Campbell's Urology. 8th Ed. Philadelphia: Saunders; 2002, Vol. 3, p. 2231-61.
Baskin LS, Kogan BA, Duckett JW. Handbook of Pediatric Urology. 2nd. Ed. Lippincott-Raven; 2005, p. 38-45.
Hammer O. PAST version 1.75b Disponible en: http://folk.uio.no/ohammer/past
Lapides J, et al. Clean, intermittent self catheterization in the treatment of urinary tract disease. J Urol 1972; 107: 458-61. Reprinted: J Urol
; 167: 1584-6.
Geranoitis E, Koff SA, Enrile B. Prophylactic use of clean intermittent catheterization in treatment of infants and young children with myelomeningocele and neurogenic bladder dysfunction. J Urol 1988; 139: 85-6.
Kochakarn W, Ratana-Olarn K, Lertsithichai P, Roongreungsilp U. Follow-up of long-term treatment with clean intermittent catheterization for neurogenic bladder in children. Asian J Surg 2004; 27(2): 134-6.
Kasabian NG, Bauer SB, Dyro FM, et al. The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration. Am J Dis Chid 1992; 146: 840-3.